Comparative Characterization and Evaluation of WS6 Loaded Nanoformulations Using Solid Lipid, PLGA, and PCL Versus Eudragit RS/RL Prepared by Microfluidics
Open Access
- 30 December 2025
- journal article
- research article
- Published by MDPI AG in Applied Nano
- Vol. 7 (1) , 1
Abstract
Objectives: This study aimed to optimize WS6-loaded nanoparticles (NPs) with favorable therapeutic properties, including appropriate size, low toxicity, high encapsulation efficiency, and enhanced biocompatibility, for selective cancer targeting and regenerative applications. Methods: Three formulations were investigated: solid lipid nanoparticles (SLNs), polycaprolactone (PCL)-based NPs, and Eudragit RS100-based NPs via microfluidic synthesis. Their physicochemical properties were assessed, followed by biological evaluation on normal cells—dental-derived stem cells (DSCs), gingival fibroblasts (GFs), and human dermal fibroblasts (HDFs)—and cancer cell lines MDA-231 and HepG2. Assays included MTT for viability, apoptosis/necrosis, cell cycle analysis, ROS detection, and cytokine profiling. Results: SLNs showed inherent toxicity despite improved viability upon WS6 loading. PCL NPs improved encapsulation and compatibility but lacked stability. The microfluidic RS-WS6 NPs exhibited optimal characteristics, significantly enhancing viability in normal cells and selectively inducing apoptosis in cancer cells. At 1 µM, RS-WS6 NPs reduced ROS in normal cells (p < 0.05) and increased it in cancer cells (p < 0.05). Cytokine analysis revealed significant downregulation of IL-6, IL-12p70, and TNF-α (p < 0.05), indicating immunomodulatory potential. Conclusions: RS-WS6 NPs developed via microfluidics offer a promising therapeutic platform with selective cytotoxicity against cancer cells, minimal toxicity to normal cells, and anti-inflammatory properties, supporting their use in targeted therapy and regenerative medicine.Keywords
Funding Information
- Ministry of Higher Education (#MPH/1/59/2023)
- Deanship of Scientific Research at the University of Petra
This publication has 38 references indexed in Scilit:
- WS6 and 5-iodotubercidin small molecules and growth factors; TGF, HGF, and EGF synergistically enhance proliferation of β-like human induced pluripotent stem cells (iPSCs)Journal of Diabetes & Metabolic Disorders, 2024
- Synthesis of nanoparticles via microfluidic devices and integrated applicationsMicrochimica Acta, 2023
- Microfluidic Nanoparticles for Drug DeliverySmall, 2022
- Toxicology of Nanoparticles in Drug DeliveryCurrent Pathobiology Reports, 2021
- Prediction of the enhanced insulin absorption across a triple co-cultured intestinal model using mucus penetrating PLGA nanoparticlesInternational Journal of Pharmaceutics, 2020
- A review on novel methodologies for drug nanoparticle preparation: Microfluidic approachChemical Engineering Research and Design, 2020
- Nanomanufacturing through microfluidic-assisted nanoprecipitation: Advanced analytics and structure-activity relationshipsInternational Journal of Pharmaceutics, 2017
- On the Dependency of Cellular Protein Levels on mRNA AbundanceCell, 2016
- Gold Nanoparticles Downregulate Interleukin‐1β‐Induced Pro‐Inflammatory ResponsesSmall, 2012
- Engineered nanoparticles as precise drug delivery systemsJournal of Cellular Biochemistry, 2006